Canary Cry News Talk cover image

PLANE REPTILIAN MARBLES

Canary Cry News Talk

00:00

Pfizer Backs CRISPR Biotech Caribou and Latest Cell Therapy Investment

Pfizer bought $25 million worth of stock and caribou biosciences, giving the gene editing company a boost of funding for an experimental multiple myeloma treatment. Caribou shares jumped more than 60% close to $7 a piece in early trading Thursday. Moderna agrees deal in China with view to developing MRNA medicines.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app